683 Capital Management’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

683 Capital Management’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-600,000	Closed	-$447K	–	253
2024 Q4	$447K	Hold	600,000	–	–	0.03%	156
2024 Q3	$732K	Hold	600,000	–	–	0.06%	107
2024 Q2	$1.24M	Buy	600,000 +485,000	+422%	+$1.14M	0.09%	97
2024 Q1	$420K	Hold	115,000	–	–	0.03%	98
2023 Q4	$346K	Sell	115,000 -393,242	-77%	-$797K	0.03%	106
2023 Q3	$1.09M	Buy	508,242 +33,242	+7%	+$133K	0.09%	99
2023 Q2	$2.66M	Sell	475,000 -55,310	-10%	-$433K	0.19%	88
2023 Q1	$3.2M	Buy	530,310 +503,009	+1,842%	+$3.5M	0.24%	101
2022 Q4	$156K	Buy	+27,301	New	+$153K	0.01%	216

Other funds holding OMGA

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

683 Capital Management's OMGA Position: Q1 2025 in Review

683 Capital Management sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 600,000 shares — an estimated $447K sold.

683 Capital Management first reported a position in OMGA in Q4 2022 and held it in 9 quarters. The position peaked at $3.2M in Q1 2023. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

683 Capital Management reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
683 Capital Management sold 600,000 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $447K.
683 Capital Management first reported a position in Omega Therapeutics, Inc. Common Stock in Q4 2022 and held it in 9 quarters.
683 Capital Management's Omega Therapeutics, Inc. Common Stock position peaked at $3.2M in Q1 2023.
4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on 683 Capital Management's 13F filing for Q1 2025, filed 15 May 2025.